# Earli

holds a patent for "methods and compositions for synthetic biomarkers" and presented early-cancer-detection data at AACR annual meetings and in Nature Communications, engineering constructs that localize to tumor tissue and amplify an otherwise sub-detectable signal.

Source: https://en.bioecon.ru/companies/earli/
Updated: 2026-07-20

- Country: United States

## Technologies

- [Synthetic biomarkers](https://en.bioecon.ru/technology/synthetic-biomarkers/)